Influenza: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(→‎Diagnosis: started lab section)
imported>Robert Badgett
Line 106: Line 106:


===Laboratory tests===
===Laboratory tests===
Rapid tests include [[immunofluorescence]] assays, [[immunoenzyme technique]], and [[polymerase chain reaction]] testing.
Rapid tests include [[immunofluorescence]] assays, [[immunoenzyme technique]], and [[polymerase chain reaction]] testing. The [[sensitivity|sensitivity and specificity]] of these tests range from 63% to 95%.<ref>Beyer WE. Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis. Vaccine. 2006 Nov 10;24(44-46):6602-4. Epub 2006 Jun 8.
PMID 16797799</ref><ref>Rodriguez WJ, Schwartz RH, Thorne MM. Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J. 2002 Mar;21(3):193-6. PMID 12005080</ref>


===Differential diagnosis===
===Differential diagnosis===

Revision as of 16:22, 19 November 2008

This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Influenza&printable=yes
This editable Main Article is under development and subject to a disclaimer.
An electron tomography of the influenza virus.

Influenza, commonly called “the ‘Flu”, is described as "an acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the nasal mucosa; the pharynx; and conjunctiva, and by headache and severe, often generalized, myalgia".[1] It is contagious (easily passed from one person to another) and is caused by viruses of the Orthomyxoviridae family.

Hosts

Influenza in humans

Symptoms of Influenza include headache, coughing and other cold-like symptoms. These are accompanied by a high fever. The flu is easily treated with modern medicines, but many strains are nevertheless quite serious, particularly for children and older persons.

Equine Influenza

This is a species-specific strain that infects horses, ponies, donkeys and mules. Humans do not catch this disease but are carriers of it. It is airborne and highly contagious. Equine influenza generally does not kill its victims, and affected horses display similar symptoms to those of humans.

In 2007, a horse flu epidemic began in New South Wales, Australia. The outbreak is believed to have begun as a result of infractions of proper quarantine procedure and is expected to cost millions of dollars in lost revenue. As of September, 2007, it had spread to the Victorian border, causing the cancellation of events at the Melbourne Show, and the possibility that the Spring Carnival, including the running of the Melbourne Cup horse race, would be canceled.

Avian flu

Avian flu, also known as Bird flu or H5N1, has led to recent outbreaks.[2][3]

Epidemiology

Seasonal influenza activity in the United States over four years. During the off season, the prevalence is < 2%. During the height of season, the prevalence may be 20-35%.[4] In the United States, the Centers for Disease Control and Prevention (CDC) maintains public statistics at http://www.cdc.gov/flu/weekly/fluactivity.htm.

Google maintains statistics based on search terms (http://www.google.org/flutrends/).[5]

The prevalence of influenza among people who have an "influenza-like illness" varies strongly with the seasons of the year. In the United States, the Centers for Disease Control and Prevention (CDC) maintains public statistics at http://www.cdc.gov/flu/weekly/fluactivity.htm.

  • During the off season, the the prevalence is < 2%[4]
  • During the height of season, the prevalence may be 20-35%.[4]
  • During local outbreaks, the prevalence may be 50-80% according to studies.[6][7] Unfortunately, the CDC does not report sufficient details to determine where local outbreaks are occurring.

In addition to seasonal variations, there have been several worldwide influenza epidemics, resulting in millions of deaths.

Diagnosis

History and physical examination

Since anti-viral drugs are effective in treating influenza if given early (see treatment section, below), it can be important to identify cases early. A systematic review by the Rational Clinical Examination concluded that the best findings for excluding the diagnosis of influenza are:[8]

Most sensitive individual findings for diagnosing influenza[8]
Finding: Sensitivity Specificity
Fever 86% 25%
Cough 98% 23%
Nasal congestion 70–90% 20–40%
Note:
* All three findings, especially fever, were less sensitive in patients over 60 years of age.[8]

Using the symptoms listed above, the combinations of findings below can improve diagnostic accuracy.[9] Unfortunately, even combinations of findings are imperfect. However, Bayes Theorem can combine pretest probability with clinical findings to adequately diagnose or exclude influenza in some patients. The pretest probability has a strong seasonal variation; the current prevalence of influenza among patients in the United States receiving sentinel testing is available at the CDC.[10] Using the CDC data, the following table shows how the likelihood of influenza varies with prevalence:

Combinations of findings for diagnosing influenza[8]
Combinations of findings Sensitivity Specificity Projected during local outbreaks
(prevalence approx 66%[11][7]) 		Projected during influenza season
(prevalence=25%)		 Projected in off-season
(prevalence=2%)
PPV NPV PPV NPV PPV NPV
Fever and cough 64% 67% 79% 49% 39% 15% 4% 1%
Fever and cough and sore throat 56 71 79 45 39 17 4 2
Fever and cough and nasal congestion 59 74 81 48 43 16 4 1

Laboratory tests

Rapid tests include immunofluorescence assays, immunoenzyme technique, and polymerase chain reaction testing. The sensitivity and specificity of these tests range from 63% to 95%.[12][13]

Differential diagnosis

Influenza-like illness is defined as "fever (temperature of 100°F [37.8°C] or greater) and a cough and/or a sore throat in the absence of a known cause other than influenza."[14] A study from Australia found that possible causes for influenza-like illness include respiratory syncytial virus, rhinovirus, adenovirus, parainfluenza viruses, coronaviruses, and metapneumovirus.[15]

Other diagnoses to consider are:

Treatment

The two classes of anti-virals are neuraminidase inhibitors and M2 inhibitors (adamantane derivatives). Neuraminidase inhibitors are currently preferred for flu virus infections.

Different strains of influenza virus have differing degrees of resistance against these antivirals and it is impossible to predict what degree of resistance a future pandemic strain might have.[16]

When to treat

According to two decision analysis studies of adults, treatment may be justified in the following settings:

  • Elderly patients if the probability of influenza is over 15%[7]
  • Adults if the probability of influenza is over 30%[6].

During local outbreaks of influenza, the prevalence will be over 50-80%[11][7] and thus patients with any of the above combinations of symptoms may be treated with neuramidase inhibitors without testing. In the absence of a local outbreak, treatment may be justified in the elderly during the influenza season as long as the prevalence is over 15%.[7]

Neuraminidase inhibitors

These drugs are often effective against both influenza A and B.[17] Examples are oseltamivir (trade name Tamiflu) and zanamivir (trade name Relenza) are neuraminidase inhibitors.[18] The Cochrane Collaboration concluded that these drugs reduce symptoms and complications.[19] Zanamivir may cause bronchospasm in patients with asthma.

M2 inhibitors (adamantanes)

These drugs are sometimes effective against influenza A if given early in the infection, but are always ineffective against influenza B. Examples include the antiviral drugs amantadine and rimantadine which block a viral ion channel and prevent the virus from infecting cells. [17]

Prevention

Vaccination

In the United States, the Centers for Disease Control and Prevention has published recommendations on who should get the influenza vaccination.[20] Protection from infection occurs by two weeks after vaccination and lasts one year.[20]

Neuraminidase inhibitors

The Cochrane Collaboration has concluded that neuraminidase inhibitors can prevent symptomatic influenza.[19] Zanamivir may cause bronchospasm in patients with asthma. In addition, oseltamivir may reduce the incidence of respiratory complications on one of 13 patients who take it (number needed to treat = 13).[21] This trial only included patients up to 65 years old.

History

Spanish influenza pandemic of 1918

A pandemic of Spanish Influenza swept across Europe in the wake of the Great War (1918-19). More people are believed to have died of the flu in the year after the war then in the Great War itself. Estimates vary but it is estimated that one third of the world's population were infected and up to 50 million people perished in this pandemic (it is possibly that fatalities world wide were as high as 100 million).[22] Some comparisons are drawn between Spanish Flu and the Black Death (Bubonic Plague) of 1347 to 1351. Estimates are that the flu killed more people in one year than plague did in four.

In the United States, the epidemic led to closing of schools and banning of public meetings in order to successfully reduce mortality.[23]


References

  1. ↑ National Library of Medicine. "Influenza". [e]
  2. ↑ Oner AF, Bay A, Arslan S, et al (2006). "Avian influenza A (H5N1) infection in eastern Turkey in 2006". N. Engl. J. Med. 355 (21): 2179–85. DOI:10.1056/NEJMoa060601. PMID 17124015. Research Blogging.
  3. ↑ Kandun IN, Wibisono H, Sedyaningsih ER, et al (2006). "Three Indonesian clusters of H5N1 virus infection in 2005". N. Engl. J. Med. 355 (21): 2186–94. DOI:10.1056/NEJMoa060930. PMID 17124016. Research Blogging.
  4. ↑ 4.0 4.1 4.2 Centers for Disease Control and Prevention. Flu Activity. Retrieved on 2007-11-29.
  5. ↑ Helft M (Nov 11, 2008). Google Uses Web Searches to Track Flu’s Spread - NYTimes.com. New York Times Company. Retrieved on 2008-11-11.
  6. ↑ 6.0 6.1 Smith K, Roberts M (2002). "Cost-effectiveness of newer treatment strategies for influenza.". Am J Med 113 (4): 300-7. DOI:10.1016/S0002-9343(02)01222-6. PMID 12361816. Research Blogging.
  7. ↑ 7.0 7.1 7.2 7.3 7.4 Rothberg M, Bellantonio S, Rose D (2003). "Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.". Ann Intern Med 139 (5 Pt 1): 321-9. PMID 12965940.
  8. ↑ 8.0 8.1 8.2 8.3 Call S, Vollenweider M, Hornung C, Simel D, McKinney W (2005). "Does this patient have influenza?". JAMA 293 (8): 987-97. DOI:10.1001/jama.293.8.987. PMID 15728170. Research Blogging.
  9. ↑ Monto A, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000). "Clinical signs and symptoms predicting influenza infection.". Arch Intern Med 160 (21): 3243–7. PMID 11088084.
  10. ↑ Centers for Disease Control and Prevention. Weekly Report: Influenza Summary Update. Accessed January 1, 2007.
  11. ↑ 11.0 11.1 Smith K, Roberts M (2002). "Cost-effectiveness of newer treatment strategies for influenza.". Am J Med 113 (4): 300-7. DOI:10.1016/S0002-9343(02)01222-6. PMID 12361816. Research Blogging.
  12. ↑ Beyer WE. Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis. Vaccine. 2006 Nov 10;24(44-46):6602-4. Epub 2006 Jun 8. PMID 16797799
  13. ↑ Rodriguez WJ, Schwartz RH, Thorne MM. Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J. 2002 Mar;21(3):193-6. PMID 12005080
  14. ↑ Centers for Disease Control and Prevention (2007). CDC - Influenza (Flu) - Flu Activity. Retrieved on 2007-11-19.
  15. ↑ Kelly H, Birch C (2004). "The causes and diagnosis of influenza-like illness". Australian family physician 33 (5): 305–9. PMID 15227858. [e]
  16. ↑ Webster, Robert G. (2006). "H5N1 Influenza — Continuing Evolution and Spread". N Engl J Med 355 (21): 2174–77. PMID 16192481.
  17. ↑ 17.0 17.1 Stephenson, I; Nicholson K (1999). "Chemotherapeutic control of influenza". J Antimicrob Chemother 44 (1): 6–10. PMID 10459804.
  18. ↑ Moscona, A (2005). "Neuraminidase inhibitors for influenza". N Engl J Med 353 (13): 1363–73. PMID 16192481.
  19. ↑ 19.0 19.1 Jefferson, T; Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. "Neuraminidase inhibitors for preventing and treating influenza in healthy adults". Cochrane Database Syst Rev 3: CD001265. DOI:10.1002/14651858.CD001265.pub2. PMID 16855962. Research Blogging.
  20. ↑ 20.0 20.1 Centers for Disease Control and Prevention. CDC - Influenza (Flu): Vaccination. Retrieved on 2007-11-29.
  21. ↑ Treanor JJ, Hayden FG, Vrooman PS, et al (2000). "Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group". JAMA 283 (8): 1016–24. PMID 10697061. [e]
  22. ↑ http://www.cdc.gov/ncidod/EID/vol12no01/05-0979.htm
  23. ↑ Markel H, Lipman HB, Navarro JA, et al (2007). "Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic". JAMA 298 (6): 644–54. DOI:10.1001/jama.298.6.644. PMID 17684187. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Influenza&oldid=286056"